Current Studies

J2V-MC-GZLF (Weight Management & T2D)

A Study to Investigate Weight Reduction with Macupatide and Eloralintide, Alone or in Combination, in Adult Participants with Obesity or Overweight and with Type 2 Diabetes.

NN9490-8026 (AMAZE 5),
NN9490-8294 (AMAZE 6)

If you are living with overweight or obesity and knee osteoarthritis (OA) pain, you may be able to take part in a clinical research study evaluating an investigational medication for weight management and OA-related pain.

EP-104IAR-102 (RESOLVE)

EoE Uniquit One

If you’ve been diagnosed with Eosinophilic Esophagitis and still experience symptoms when you swallow, eat or live your day-to-day life, you may be able to take part in a clinical research study evaluating an investigational medication.

REGISTER YOUR INTEREST

Clinical trials are important because they serve as the foundation for most medical advances. Without clinical trials, many of the medical treatments and cures we have today wouldn’t exist.

The following studies are no longer recruiting.

OD-07656-201 (ODYSSEY)

A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy.

Coeliac Chugai Study (Asymptomatic)

A Phase IC, randomized, double-blind, placebo-controlled trial.

EoE Uniquity One – (NSI-8226-201)

EoE Uniquit One

A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study.

LUMEN (LMN-401)

A clinical trial to assess the intraluminal pharmacokinetics (PK) of LMN-401.

Eosinophilic Esophagitis

Eosinophilic Esophagitis

Non-Steroidal Treatment Option for Eosinophilic Esophagitis.

Ulcerative Colitis (2)

Ulcerative Colitis

Head-to-Head Comparative Study for Moderate-Severe Ulcerative Colitis (Ucesive Study) – No placebo risk.

Coeliac Disease

Coeliac Disease

Capsule to Treat Refractory Coeliac Disease despite a gluten free diet.

Weight loss (Osteoarthritis of the Knee)

Weight Loss

Treatment for weight loss in participants with Osteoarthritis of the Knee (Triumph-4).

Weight loss (Cardiovascular Disease)

Weight Loss CV

Treatment for weight loss in participants that have Cardiovascular Disease (Triumph-3).

Ulcerative Colitis (Duet)

Ulcerative Colitis

New investigative IV therapy to Treat Moderate-Severe Ulcerative Colitis.

Coeliac CEC-013/CEL (Symptomatic)

Celiac

A phase II, double-blind, randomised, placebo-controlled trial.

IBS ANR-GARP-001

IBS ANR-GARP-001

A Randomized, Double-blind, Placebo-controlled clinical trial.

Weight Management (ASCEND)

A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy.

Crohn’s Disease

Crohn’s Disease

Tablet to treat Moderate to Severe Crohn’s Disease (Yellowstone Study).

Weight Management
Clinical Trial (Osteoarthritis)

Weight Management Clinical Trial (Osteoarthritis)

Patient information evening finished.

Weight Management
Clinical Trial (Cardiovascular)

Weight Management Clinical Trial (Cardiovascular)

Patient information evening finished.

TV53408-IMM-20042 (TEVA)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Trial to Characterize the Efficacy and Safety of TEV-53408 in Adults with Coeliac Disease while undergoing Oral Gluten Exposure.